Trial Profile
Pharmacokinetics, Glucodynamics, Safety, and Tolerability of Multiple LY900014 Formulations
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 May 2020
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 25 Feb 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 07 Jan 2016 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 25 Dec 2015 New trial record